Outcomes of ultrasound-guided injections of Bennett lesions of the shoulder

Purpose: To describe our technique and short term follow up of ultrasound-guided injections of symptomatic Bennett lesions.

Methods: We performed 13 ultrasound-guided injections in 10 baseball players from August 2014 to August 2021. The cohort was comprised of 10 males, with a mean age of 25 years and 1 month (age range: 17 years, 10 months-33 years, 1 month). Of the 10 patients, 6 were major league baseball players (including 5 pitchers and a second baseman), 3 were minor league baseball pitchers; and 1 pitched in high school. Symptoms in our patients included posterior shoulder pain at rest, pain with pitching (including in the acceleration phase and with follow-through), glenoid internal reduction deficit, and decreased pitching velocity. The procedure was performed in a similar fashion as a standard posterior approach glenohumeral injection, though with the linear transducer positioned slightly more medially. The needle was inserted from a lateral to medial approach, in plane with the transducer and aimed to the superficial surface of the Bennett lesion, onto which anesthetic and steroid was injected, avoiding injection into the glenohumeral joint.

Results: All patients had MRIs that showed Bennett lesions and all but one of the sonograms demonstrated the Bennett lesion. In 8/12 (67%) injections, the patient reported varying degrees of immediate symptom relief. In 4/12 injections, patients were unable to assess for immediate postprocedural change in symptomatology and for one patient post-procedural symptomatology was not documented. No complications occurred. Analytics of the average 4-seam fastball velocity was available for 2 of the major league players who had in-season injections, with minimal change in postprocedural velocity in the year after their ultrasound procedure; for one of the pitchers, his fastball velocity slightly increased in the month after the procedure while the other pitcher had his injection towards the end of the season and he threw no fastballs in his final games of the season. Two of the other professional pitchers went on to surgical intervention and neither returned to pitch professionally.

Conclusion: Injection of symptomatic Bennett lesions is a safe procedure and can provide symptomatic relief that may be temporary, though equivocally useful clinically.